Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-097515
Filing Date
2014-03-13
Accepted
2014-03-13 15:22:08
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d652807d10k.htm 10-K 1325892
2 EX-10.34 d652807dex1034.htm EX-10.34 147125
3 EX-10.35 d652807dex1035.htm EX-10.35 38589
4 EX-10.36 d652807dex1036.htm EX-10.36 49015
5 EX-23.1 d652807dex231.htm EX-23.1 2125
6 EX-31.1 d652807dex311.htm EX-31.1 7472
7 EX-31.2 d652807dex312.htm EX-31.2 7253
8 EX-32.1 d652807dex321.htm EX-32.1 7320
15 GRAPHIC g652807g97l93.jpg GRAPHIC 55775
  Complete submission text file 0001193125-14-097515.txt   7921390

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT orex-20131231.xml EX-101.INS 1021606
10 XBRL TAXONOMY EXTENSION SCHEMA orex-20131231.xsd EX-101.SCH 64882
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20131231_cal.xml EX-101.CAL 69223
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20131231_def.xml EX-101.DEF 369142
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20131231_lab.xml EX-101.LAB 540961
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20131231_pre.xml EX-101.PRE 424606
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 14690803
SIC: 2834 Pharmaceutical Preparations